- Home
- ABSI vs LFCR Comparison
ABSI vs LFCR Comparison
Compare ABSI & LFCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABSI
- LFCR
- Stock Information
- Founded
- ABSI 2011
- LFCR 1986
- Country
- ABSI United States
- LFCR United States
- Employees
- ABSI N/A
- LFCR N/A
- Industry
- ABSI Biotechnology: Pharmaceutical Preparations
- LFCR Biotechnology: Pharmaceutical Preparations
- Sector
- ABSI Health Care
- LFCR Health Care
- Exchange
- ABSI Nasdaq
- LFCR Nasdaq
- Market Cap
- ABSI 338.0M
- LFCR 308.8M
- IPO Year
- ABSI 2021
- LFCR N/A
- Fundamental
- Price
- ABSI $2.62
- LFCR $7.68
- Analyst Decision
- ABSI Strong Buy
- LFCR Buy
- Analyst Count
- ABSI 5
- LFCR 4
- Target Price
- ABSI $7.98
- LFCR $8.00
- AVG Volume (30 Days)
- ABSI 4.1M
- LFCR 123.1K
- Earning Date
- ABSI 11-11-2025
- LFCR 10-03-2025
- Dividend Yield
- ABSI N/A
- LFCR N/A
- EPS Growth
- ABSI N/A
- LFCR N/A
- EPS
- ABSI N/A
- LFCR N/A
- Revenue
- ABSI $4,138,000.00
- LFCR $128,867,000.00
- Revenue This Year
- ABSI $44.71
- LFCR $4.71
- Revenue Next Year
- ABSI $374.26
- LFCR $10.98
- P/E Ratio
- ABSI N/A
- LFCR N/A
- Revenue Growth
- ABSI 27.32
- LFCR 0.47
- 52 Week Low
- ABSI $2.01
- LFCR $4.33
- 52 Week High
- ABSI $6.33
- LFCR $8.85
- Technical
- Relative Strength Index (RSI)
- ABSI 49.98
- LFCR 53.40
- Support Level
- ABSI $2.37
- LFCR $7.00
- Resistance Level
- ABSI $2.89
- LFCR $7.82
- Average True Range (ATR)
- ABSI 0.15
- LFCR 0.41
- MACD
- ABSI 0.03
- LFCR 0.01
- Stochastic Oscillator
- ABSI 52.63
- LFCR 40.24
About ABSI Absci Corporation
Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.
About LFCR Lifecore Biomedical Inc.
Lifecore Biomedical Inc is a fully integrated contract development and manufacturing organization (CDMO) that offers differentiated capabilities in the development, filling, and finishing of complex sterile injectable pharmaceutical products in syringes and vials. It manufactures injectable-grade Hyaluronic Acid. Lifecore recognizes revenue in two different product categories, CDMO and fermentation.